2 results match your criteria: "The Federal Institute for Drugs and Medical Devices (BfArM)[Affiliation]"
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.
Stat Biopharm Res
July 2020
Department of Mathematics and Statistics, Lancaster University, Lancaster, UK.
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible.
View Article and Find Full Text PDFThe European Medicines Agency (EMA) revises its guideline on minimizing risk in first-in-human trials to reflect changing practice and in light of a recent tragic incident.
View Article and Find Full Text PDF